Independent service organization InnoServ Technologies of Corona,CA, has named Michael Puls as president and CEO. Puls fills aleadership role formerly held by Alan Margulis, who left the companyin March (SCAN 3/29/95). Puls moves to InnoServ from Senmed
Independent service organization InnoServ Technologies of Corona,CA, has named Michael Puls as president and CEO. Puls fills aleadership role formerly held by Alan Margulis, who left the companyin March (SCAN 3/29/95). Puls moves to InnoServ from Senmed MedicalVentures, which specializes in medical venture capital financing.
InnoServ reported second-quarter financial results (end-October)earlier this month. Revenues were $11.9 million with net incomeof $185,000, compared to sales of $13.4 million and a net lossof $528,000 in the same period last year.
For the first six months of the year, InnoServ posted revenuesof $23.9 million with net income of $71,000, compared to revenuesof $22.1 million and a net loss of $1.1 million in the same periodin 1994. InnoServ also announced that it had received a five-year$5.5 million contract for biomedical and clinical lab repair servicesat Children's Hospital in Columbus, OH.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.